An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.

Authors

David J Andorsky
Kathryn S Kolibaba
Sarit Assouline
Andres Forero-Torres
Vicky Jones
Leonard M Klein
Dipti Patel-Donnelly
Mitchell Smith, George Washington University
Wei Ye
Wen Shi
Christopher A Yasenchak
Jeff P Sharman

Document Type

Journal Article

Publication Date

9-5-2018

Journal

British journal of haematology

DOI

10.1111/bjh.15552

Comments

epub ahead of print

APA Citation

Andorsky, D., Kolibaba, K., Assouline, S., Forero-Torres, A., Jones, V., Klein, L., Patel-Donnelly, D., Smith, M., Ye, W., Shi, W., Yasenchak, C., & Sharman, J. (2018). An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.. British journal of haematology, (). http://dx.doi.org/10.1111/bjh.15552

Peer Reviewed

1